REPEAT: Glaxo's Zejula And GSK3359609 Perform Well In Cancer Studies
REPEAT: Glaxo's Zejula And GSK3359609 Perform Well In Cancer Studies
Read moreREPEAT: Glaxo's Zejula And GSK3359609 Perform Well In Cancer Studies
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* STOXX 600 ends Sept up 3.4%* Euro down 0.3% on worries about euro-zone growth* JPMorgan raises euro zone equities to "overweight" (Updates to close)By Susan MathewSept 30 (Re...
Read more* Trade-sensitive tech stocks fall 0.2%* STOXX 600 set to end Sept up 3%* JPMorgan raises euro zone equities to "overweight" (Adds comments; updates market action)By Shreyashi Sanyal and Sagarika JaisinghaniSept 30 (Reuters) - European shares were...
Read more* FTSE 100, FTSE 250 about flat* Trade tensions, Brexit uncertainty curb risk sentiment* GSK rises after ovarian cancer study results* Metro Bank jumps on report Elliott considering taking stake (Adds news items, analyst comment, updates share pric...
Read moreLONDON MARKET OPEN: Stocks Start Tentatively Higher; UK GDP To Come
Read more* European shares open down slightly * Asian shares flat Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Josephine Mason. Reach her on Messenger to sh...
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* FTSE 100, FTSE 250 about flat* Trade tensions linger* Brexit uncertainty also curbs risk sentimentSept 30 (Reuters) - UK shares were steady on Monday as investors largely opt...
Read more* Drug candidates are in class known as PARP inhibitors* Companies to discuss results with healthcare regulators (Adds details on patient subgroup, sales estimates)By Ludwig BurgerBARCELONA, Sept 28 (Reuters) - GlaxoSmithKline and AstraZeneca both ...
Read moreBy Ludwig BurgerBARCELONA, Sept 28 (Reuters) - GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian cancer patients, possibly helping GSK catch its rival in a...
Read more* British firms to square off at oncology meeting* Investors seek insights from Zejula, Lynparza trials* Readouts could be indicative of size of future marketsBy Ludwig BurgerSept 26 (Reuters) - GlaxoSmithKline and AstraZeneca will each present tria...
Read moreGlaxoSmithKline Pours More Money Into US Manufacturing Capabilities
Read more* FTSE 100 up 0.3%, FTSE 250 down 0.2%* Sterling shaky ahead of ruling on British parliament suspension* Blue-chip financial stocks bounce back* U.S.-China trade sentiment also supports market mood* Metro Bank falls after ditching bond issue (Adds ...
Read moreOncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks
Read moreBy Deena BeasleySept 19 (Reuters) - U.S. President Donald Trump on Thursday signed an executive order aimed at spurring the development of better vaccines to protect against seasonal influenza as well as a potential pandemic flu outbreak.The order...
Read more(Adds details of vaccine, statement from WHO Africa director)NAIROBI, Sept 13 (Reuters) - Kenya on Friday began adding a malaria vaccine to its routine immunization schedule for babies and toddlers, becoming the third African country to roll out th...
Read more